VITAMIN D AND PERITONEAL DIALYSISBANKS, Mindy; SPRAGUE, Stuart M.Peritoneal dialysis international. 2008, Vol 28, issn 0896-8608, S33-S37, SUP2Article

Effect of Vitamin D Receptor Activator Therapy on Vitamin D Receptor and Osteocalcin Expression in Circulating Endothelial Progenitor Cells of Hemodialysis PatientsCIANCIOLO, Giuseppe; LA MANNA, Gaetano; DONATI, Gabriele et al.Blood purification. 2013, Vol 35, Num 1-3, pp 187-195, issn 0253-5068, 9 p.Article

Vitamin D Therapy in Cardiac Hypertrophy and Heart Failure : Novel Pharmacological Therapies for Cardiac Hypertrophy and Heart FailureWU-WONG, J. Ruth.Current pharmaceutical design (Print). 2011, Vol 17, Num 18, pp 1794-1807, issn 1381-6128, 14 p.Article

Chronic inflammation in the pathogenesis of benign prostatic hyperplasiaFIBBI, B; PENNA, G; MORELLI, A et al.International journal of andrology (Print). 2010, Vol 33, Num 3, pp 475-488, issn 0105-6263, 14 p.Article

A novel nonsecosteroidal VDR agonist (CH5036249) exhibits efficacy in a spontaneous benign prostatic hyperplasia beagle modelTANIGUCHI, K; KATAGIRI, K; KATO, A et al.Journal of steroid biochemistry and molecular biology. 2010, Vol 121, Num 1-2, pp 204-207, issn 0960-0760, 4 p.Conference Paper

The selective vitamin D receptor agonist, elocalcitol, reduces endometriosis development in a mouse model by inhibiting peritoneal inflammationMARIANI, Margherita; VIGANO, Paola; GENTILINI, Davide et al.Human reproduction (Oxford. Print). 2012, Vol 27, Num 7, pp 2010-2019, issn 0268-1161, 10 p.Article

Potential for vitamin D receptor agonists in the treatment of cardiovascular disease : Advances in Nutritional PharmacologyWU-WONG, J. R.British journal of pharmacology. 2009, Vol 158, Num 2, pp 395-412, issn 0007-1188, 18 p.Article

Oral Paricalcitol Reduces the Prevalence of Posttransplant Hyperparathyroidism: Results of an Open Label Randomized TrialAMER, H; GRIFFIN, M. D; KUMAR, R et al.American journal of transplantation (Print). 2013, Vol 13, Num 6, pp 1576-1585, issn 1600-6135, 10 p.Article